Cargando…
Correlation of Gli1 and HER2 expression in gastric cancer: Identification of novel target
HER2 becomes the standard of care for guiding adjuvant treatment of gastric cancer with trastuzumab in recent years. However, the usage of this target agent is still limited because of the resistance to trastuzumab or the negative expression of HER2 in tumor tissues. The Gli1 and HER2 both play an i...
Autores principales: | Shao, Xinyu, Kuai, Xiaoyi, Pang, Zhi, Zhang, Liping, Wu, Longyun, Xu, Lijuan, Zhou, Chunli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762756/ https://www.ncbi.nlm.nih.gov/pubmed/29321573 http://dx.doi.org/10.1038/s41598-017-17435-6 |
Ejemplares similares
-
Rab1A promotes proliferation and migration abilities via regulation of the HER2/AKT-independent mTOR/S6K1 pathway in colorectal cancer
por: Cheng, Zhengwu, et al.
Publicado: (2019) -
Expression analysis and implication of Rab1A in gastrointestinal relevant tumor
por: Xu, Menglin, et al.
Publicado: (2019) -
Identification of RegIV as a Novel GLI1 Target Gene in Human Pancreatic Cancer
por: Wang, Feng, et al.
Publicado: (2011) -
Correction: Identification of RegIV as a Novel GLI1 Target Gene in Human Pancreatic Cancer
por: Wang, Feng, et al.
Publicado: (2011) -
Leaky Gut in IBD: Intestinal Barrier–Gut Microbiota Interaction
por: Yu, Shunying, et al.
Publicado: (2022)